{
    "code": "10000895",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=10000895",
    "time": "2020-01-10 03:38:14",
    "許可證字號": "衛署菌疫輸字第000895號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "114\/02\/24",
    "發證日期": "99\/02\/24",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA01000089503",
    "中文品名": "克歐維人類免疫球蛋白靜脈輸注液 100 毫克\/ 毫升",
    "英文品名": "KIOVIG 100 mg\/ml Solution for Infusion",
    "適應症": "替代療法：\r\n• 原發性免疫不全症候群(primary immunodeficiency syndrome，PID)。\r\n例如：\r\n− 先天性丙種球蛋白缺乏症(congenital agammaglobulinaemia)與低丙種\r\n球蛋白血症(hypogammaglobulinaemia)。\r\n− 常見變異性免疫不全症(common variable immunodeficiency)。\r\n− 嚴重複合型免疫不全症(severe combined immunodeficiencies)。\r\n− Wiskott Aldrich症候群(X染色體性聯遺傳性免疫不全症)。\r\n• 繼發性免疫缺乏疾病(Secondary immunodeficiencies，SID)，這些病人遭受\r\n嚴重或復發性感染、對抗菌治療無效，且被證實特定抗體缺乏(proven\r\nspecific antibody failure，PSAF)或血清中IgG濃度",
    "劑型": "279注射液",
    "包裝": "10ml、25ml、50ml瓶裝 100ml、200ml瓶裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "血液衍生產品",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "1406701100  台灣武田藥品工業股份有限公司",
        "申請商地址": "台北市信義區松高路1號17樓",
        "主製造廠": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "6132051324  泛泰醫療產品股份有限公司",
            "製造廠廠址": "桃園市蘆竹區海湖里海山東街482號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠"
        },
        {
            "製造廠名稱": "FAT0018100  BAXTER AG",
            "製造廠廠址": "INDUSTRIESTRASSE 67, A-1221 WIEN, AUSTRIA",
            "製造廠公司地址": "",
            "製造廠國別": "AUSTRIA",
            "製程": "許可證持有者"
        },
        {
            "製造廠名稱": "FAT0038000  BAXTER AG",
            "製造廠廠址": "INDUSTRIESSTRASSE 131, A-1221 VIENNA, AUSTRIA",
            "製造廠公司地址": "INDUSTRIESSTRASSE 67, A-1221 VIENNA, AUSTRIA",
            "製造廠國別": "AUSTRIA",
            "製程": "血漿分層(fractionation)"
        },
        {
            "製造廠名稱": "FIT0525000  Baxter Manufacturing S.p.A",
            "製造廠廠址": "Via Della chimica 5, 02015 Santa Rufina Cittaducale, Rieti（RI）, Italy",
            "製造廠公司地址": "",
            "製造廠國別": "ITALY",
            "製程": "血漿分層(fractionation)"
        },
        {
            "製造廠名稱": "FUS0200000  BAXALTA US INC.",
            "製造廠廠址": "4501 COLORADO BOULEVARD, LOS ANGELES, CALIFORNIA 90039, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "血漿分層(fractionation)"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "8004000640",
            "成分名稱": "HUMAN NORMAL IMMUNOGLOBULIN (IVIG)",
            "含量描述": "",
            "含量": "100.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Kiovig-108-03-27(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000895&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "k 1225-108-12-25.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000895&Seq=014&Type=9"
        },
        {
            "title": "Kiovig_carton_10g100ml_LE0740199 V2_20171226 TFDA approved-108-03-27(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000895&Seq=008&Type=8"
        },
        {
            "title": "020008950002-106-12-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000895&Seq=007&Type=8"
        }
    ]
}